The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice

The characteristic t(12;16)(q13;p11) chromosomal translocation, which leads to gene fusion that encodes the FUS-CHOP chimeric protein, is associated with human liposarcomas. The altered expression of FUS-CHOP has been implicated in a characteristic subgroup of human liposarcomas. We have introduced the FUS-CHOP transgene into the mouse genome in which the expression of the transgene is successfully driven by the elongation factor 1α (EF1α) promoter to all tissues. The consequent overexpression of FUS-CHOP results in most of the symptoms of human liposarcomas, including the presence of lipoblasts with round nuclei, accumulation of intracellular lipid, induction of adipocyte-specific genes and a concordant block in the differentiation program. We have demonstrated that liposarcomas in the FUS-CHOP transgenic mice express high levels of the adipocyte regulatory protein PPARγ, whereas it is not expressed in embryonic fibroblasts from these animals following induction to differentiation toward the adipocyte lineage, indicating that the in vitro system does not really reflect the in vivo situation and the developmental defect is downstream of PPARγ expression. No tumors of other tissues were found in these transgenic mice despite widespread activity of the EF1α promoter. This establishes FUS-CHOP overexpression as a key determinant of human liposarcomas and provide the first in vivo evidence for a link between a fusion gene created by a chromosomal translocation and a solid tumor.

Saved in:
Bibliographic Details
Main Authors: Pérez-Losada, J., Pintado, B., Gutiérrez Adán, Alfonso, Flores, T., Bañares-González, B., Calabia del Campo, J., Martín-Martín, J. F., Battaner, E., Sánchez-García, I.
Format: artículo biblioteca
Language:English
Published: Springer Nature 2000
Subjects:Chromosomal abnormality, Malignant solid tumors, Adipose tissue, Cancer development,
Online Access:http://hdl.handle.net/20.500.12792/3460
http://hdl.handle.net/10261/289748
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-inia-es-10261-289748
record_format koha
spelling dig-inia-es-10261-2897482023-02-16T12:23:48Z The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice Pérez-Losada, J. Pintado, B. Gutiérrez Adán, Alfonso Flores, T. Bañares-González, B. Calabia del Campo, J. Martín-Martín, J. F. Battaner, E. Sánchez-García, I. Chromosomal abnormality Malignant solid tumors Adipose tissue Cancer development The characteristic t(12;16)(q13;p11) chromosomal translocation, which leads to gene fusion that encodes the FUS-CHOP chimeric protein, is associated with human liposarcomas. The altered expression of FUS-CHOP has been implicated in a characteristic subgroup of human liposarcomas. We have introduced the FUS-CHOP transgene into the mouse genome in which the expression of the transgene is successfully driven by the elongation factor 1α (EF1α) promoter to all tissues. The consequent overexpression of FUS-CHOP results in most of the symptoms of human liposarcomas, including the presence of lipoblasts with round nuclei, accumulation of intracellular lipid, induction of adipocyte-specific genes and a concordant block in the differentiation program. We have demonstrated that liposarcomas in the FUS-CHOP transgenic mice express high levels of the adipocyte regulatory protein PPARγ, whereas it is not expressed in embryonic fibroblasts from these animals following induction to differentiation toward the adipocyte lineage, indicating that the in vitro system does not really reflect the in vivo situation and the developmental defect is downstream of PPARγ expression. No tumors of other tissues were found in these transgenic mice despite widespread activity of the EF1α promoter. This establishes FUS-CHOP overexpression as a key determinant of human liposarcomas and provide the first in vivo evidence for a link between a fusion gene created by a chromosomal translocation and a solid tumor. 2023-02-16T12:23:48Z 2023-02-16T12:23:48Z 2000 artículo Oncogene 19(20): 2413-2422 (2000) 0950-9232 http://hdl.handle.net/20.500.12792/3460 http://hdl.handle.net/10261/289748 10.1038/sj.onc.1203572 1476-5594 en none Springer Nature
institution INIA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-inia-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del INIA España
language English
topic Chromosomal abnormality
Malignant solid tumors
Adipose tissue
Cancer development
Chromosomal abnormality
Malignant solid tumors
Adipose tissue
Cancer development
spellingShingle Chromosomal abnormality
Malignant solid tumors
Adipose tissue
Cancer development
Chromosomal abnormality
Malignant solid tumors
Adipose tissue
Cancer development
Pérez-Losada, J.
Pintado, B.
Gutiérrez Adán, Alfonso
Flores, T.
Bañares-González, B.
Calabia del Campo, J.
Martín-Martín, J. F.
Battaner, E.
Sánchez-García, I.
The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
description The characteristic t(12;16)(q13;p11) chromosomal translocation, which leads to gene fusion that encodes the FUS-CHOP chimeric protein, is associated with human liposarcomas. The altered expression of FUS-CHOP has been implicated in a characteristic subgroup of human liposarcomas. We have introduced the FUS-CHOP transgene into the mouse genome in which the expression of the transgene is successfully driven by the elongation factor 1α (EF1α) promoter to all tissues. The consequent overexpression of FUS-CHOP results in most of the symptoms of human liposarcomas, including the presence of lipoblasts with round nuclei, accumulation of intracellular lipid, induction of adipocyte-specific genes and a concordant block in the differentiation program. We have demonstrated that liposarcomas in the FUS-CHOP transgenic mice express high levels of the adipocyte regulatory protein PPARγ, whereas it is not expressed in embryonic fibroblasts from these animals following induction to differentiation toward the adipocyte lineage, indicating that the in vitro system does not really reflect the in vivo situation and the developmental defect is downstream of PPARγ expression. No tumors of other tissues were found in these transgenic mice despite widespread activity of the EF1α promoter. This establishes FUS-CHOP overexpression as a key determinant of human liposarcomas and provide the first in vivo evidence for a link between a fusion gene created by a chromosomal translocation and a solid tumor.
format artículo
topic_facet Chromosomal abnormality
Malignant solid tumors
Adipose tissue
Cancer development
author Pérez-Losada, J.
Pintado, B.
Gutiérrez Adán, Alfonso
Flores, T.
Bañares-González, B.
Calabia del Campo, J.
Martín-Martín, J. F.
Battaner, E.
Sánchez-García, I.
author_facet Pérez-Losada, J.
Pintado, B.
Gutiérrez Adán, Alfonso
Flores, T.
Bañares-González, B.
Calabia del Campo, J.
Martín-Martín, J. F.
Battaner, E.
Sánchez-García, I.
author_sort Pérez-Losada, J.
title The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
title_short The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
title_full The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
title_fullStr The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
title_full_unstemmed The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice
title_sort chimeric fus/tls-chop fusion protein specifically induces liposarcomas in transgenic mice
publisher Springer Nature
publishDate 2000
url http://hdl.handle.net/20.500.12792/3460
http://hdl.handle.net/10261/289748
work_keys_str_mv AT perezlosadaj thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT pintadob thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT gutierrezadanalfonso thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT florest thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT banaresgonzalezb thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT calabiadelcampoj thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT martinmartinjf thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT battanere thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT sanchezgarciai thechimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT perezlosadaj chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT pintadob chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT gutierrezadanalfonso chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT florest chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT banaresgonzalezb chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT calabiadelcampoj chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT martinmartinjf chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT battanere chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
AT sanchezgarciai chimericfustlschopfusionproteinspecificallyinducesliposarcomasintransgenicmice
_version_ 1767603007376064512